Project Grant R01AG092015
Award Date
12/1/24
Completion Date
11/30/29
Dollars Obligated
$787K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This Project Grant award for $506,451 from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) aims to develop an effective targeted delivery system for small interfering RNA (siRNA) therapeutics to mitigate neuroinflammatory diseases, including Alzheimer's disease. The project leverages the awardee's 3P Biotechnologies, Inc.'s expertise in exosome engineering, drug delivery, and siRNA therapeutics. The key products or services to be delivered under this award...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,946,385.00 to Vanderbilt University over the period of August 1, 2024 to April 30, 2029 to develop novel analytical approaches to dissect cell-cell communication among microglia, astrocytes, and neurons in Alzheimer's disease (AD) progression. The key products and services to be delivered include: Developing new network-based models and statistical methods to identify cell-cell...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $835,417 to the Icahn School of Medicine at Mount Sinai to develop novel lipid nanoparticle (LNP) formulations for efficient delivery of nucleic acid-based therapeutics to the brain to treat Alzheimer's disease (AD). The key objectives are to: 1) synthesize innovative blood-brain barrier (BBB)-crossing lipids and formulate a library of LNPs, 2) engineer siRNA and mRNA sequences to modulate...
The National Institute on Aging (NIA) awarded a $792,074 Project Grant under the Aging Research program (CFDA 93.866) to the Trustees of Indiana University, doing business as Indiana University Indianapolis, to conduct research on modulating microglial activity through siRNA-mediated knockdown of the INPP5D gene as a potential treatment for Alzheimer's disease. The goal is to identify and characterize INPP5D transcriptional variants in murine models, design and validate self-delivering siRNA...
This $500,000 Project Grant awarded by the National Institute on Aging (CFDA 93.866 Aging Research) will support Sxrna Technologies, Inc. in developing an organoid toolkit for Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD). The company aims to create a platform for identifying senescent cells in living tissue, which can provide insights into the aging process and enable high-throughput drug screening in complex 3D tissue models. Specifically, the grant will fund...
The National Institute on Aging awarded a $972,000 Project Grant (CFDA 93.866 - Aging Research) to Vanderbilt University Medical Center to conduct research on the genetic factors underlying the onset of amyloid positivity in Alzheimer's disease (AD). The project aims to leverage advanced imaging and genomic analysis techniques to characterize the genetic architecture of amyloid onset and identify novel genetic drivers of this process. This work builds on the awardee's prior research...
The National Institute on Aging (NIA) awarded a $2,552,654.85 Project Grant (CFDA 93.866 - Aging Research) to Vanderbilt University Medical Center (VUMC) to systematically screen and validate drug repurposing candidates for Alzheimer's disease and related dementias (AD/ADRD). The project aims to integrate genetics, transcriptomics, literature, and clinical data using advanced informatics to develop and share tools that can identify, prioritize, and validate drug repurposing candidates and...
The National Institute on Aging (NIA) awarded a $295,000 Project Grant under the Aging Research program (CFDA 93.866) to Florida International University (FIU). The 2-year award, effective from September 15, 2024 to August 31, 2026, aims to develop a novel biotherapeutic nanogel system to target key biomarkers of Alzheimer's disease (AD). The proposed nanogels are designed to enhance blood-brain barrier penetration, inhibit amyloid-beta aggregation, and mitigate oxidative stress and...
The National Institute on Aging (NIA) awarded a $1,820,685.15 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Vanderbilt University Medical Center (VUMC) to systematically screen and validate drug repurposing candidates for Alzheimer's disease and related dementias (AD/ADRD). The project aims to integrate genetics, transcriptomics, literature, and clinical data using advanced informatics and computational approaches to identify, prioritize, and validate drug...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $4,694,672 to North Dakota State University from May 15, 2021 through April 30, 2024. The funding supports research to design a non-viral gene delivery system for delivering an APOE2 plasmid to the brain. Specifically, the university will synthesize and characterize liposomal nanoparticles loaded with chitosan-APOE2 polyplexes and modified with transferrin and cell-penetrating peptides...